At a roundtable discussion at Memorial Sloan Kettering Cancer Center, Vice President Joe Biden urged greater efforts to aggregate cancer data.
Seven years ago, when Congress sought to jumpstart the U.S. economy, few imagined that one aspect of the $800 billion stimulus program would turn electronic health records into the Tower of Babel.
The University of Maryland Marlene and Stewart Greenebaum Cancer Center has earned the designation as an NCI-designated Comprehensive Cancer Center.
What were Texas politicians and CPRIT officials thinking as they were pounded by blistering letters of resignation?
Vice President Joe Biden's National Cancer Moonshot Initiative has touched off an unprecedented national and international dialogue about cancer.
NCI is working to provide five to ten recommendations for Vice President Joe Biden's cancer moonshot program, officials said at a recent advisory committee meeting.
THE AMERICAN UROLOGICAL ASSOCIATION honored its 2016 award recipients during its 111th Annual Meeting in San Diego. William Marston Linehan received the Ramon Guiteras Award for his contributions to the art and science of urology, most notably in the identification of genes associated with different types of kidney cancers and developing new strategies for their […]
BRIGHAM & WOMEN'S HOSPITAL chose not to contest the plaintiffs' offers of proof in two medical malpractice lawsuits against the Boston hospital at a Massachusetts tribunal May 13.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA’s member companies invested an estimated $58.8 billion in research and development in 2015, up 10.3 percent from 2014, based on the 2016 PhRMA annual member survey published in the 2016 Biopharmaceutical Research Industry Profile. According to PhRMA, the biopharmaceutical industry is the most research-intensive sector of the U.S. economy, […]
The UCLA Department of Pathology and Laboratory Medicine and Leica Biosystems will collaborate in digital pathology. Product testing will be conducted with UCLA to validate digital pathology in a high-volume setting. This joint effort builds upon the existing relationship between UCLA and Leica Biosystems that was established in 2011. The pathology team at UCLA will […]
